Fabiflu Favipiravir 200 Mg Tablet

₹ 1,500/Stripe

Strength200 mg
BrandFabiflu
Packaging Size1X10 tablets
Prescription/Non prescriptionPrescription
FormTablet
Packaging TypeStrips
Country of OriginMade in India
AvailabilityIn Stock
Favipiravir tablet is an antiviral medicine containing Favipiravir as its active ingredient. It is used to treat mild-to-moderate COVID-19 disease in adults under restricted emergency use.

Exports To: United States Of America | United Kingdom | Australia | Korea | Russia

Find products similar to Fabiflu Favipiravir 200 Mg Tablet

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromNagpur
ShippingAs per delivery location

Product Video

Product Image

Fabiflu Favipiravir 200 Mg Tablet-1Fabiflu Favipiravir 200 Mg Tablet-2Fabiflu Favipiravir 200 Mg Tablet-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
02-01-2023
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Aug 2018
GST
27ACAFA0255H1ZT
Import Export Code (IEC)
ACAFA*****
Exports to
United States Of America | United Kingdom | Australia | Korea | Russia

Established in the year of 2023, We “Alchemist Overseas” are Trader, Wholesaler, Distributor and Exporter of an Pharmaceutical Tablets, Pharmaceutical Capsule, Pharmaceutical Medicines, Erectile Dysfunction Medicine, Skin Care Products, Antibiotic Medicines, Cardiovascular Drugs, Pharma Injections, Anti Cancer Drugs, Anti HIV Drugs, Steroid Injections, Veterinary Medicine, . We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Sahil Wadhwani, whose continual backing and direction have been useful to us for attaining exponential development in the current market.